(844) 230-7676
Idioma
$900,000 Liquidación Farmacéutica
abril 19, 2018
Categoría: Litigio Farmacéutico
Artículos de nuestro blog
Dupixent Cancer Risk: What Patients Need to Know About CTCL
Emerging Research Raises Questions About Dupixent’s Safety Profile Dupixent (dupilumab) has become one of the most widely prescribed biologic medications for chronic inflammatory conditions, helping over one million patients...
Leer el artículo
Talcum Powder and Ovarian Cancer Risk: What Consumers Need to Know Now
In recent years, talcum powder has moved from a household staple to the center of widespread litigation and scientific scrutiny. A growing body of research and high-profile jury verdicts has...
Leer el artículo
Depo-Provera: What Women Should Know About the Birth Control Shot and Meningioma Risk
Depo-Provera has been widely used for decades as a convenient form of birth control. Administered as an injection every three months, the contraceptive shot offers a highly effective...
Leer el artículo